Openlattice
Redwood City, US · Founded 2017 · Delaware corporation · 2 known investors
Founders & leadership
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$5.4MraisedJun 2019 · 10 investors · Other TechnologyRule 506(b)
▶$5.4MraisedJun 2019 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew Tamayo-RiosExecutive Officer, Director
- Patrick GradyDirector
- Ron BouganimDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $150K |
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.